Early prediction of ECMO-eligibility for severe ARDS in adults
J. Kyle Bohman(Mayo Clinic in Arizona), Gregory J. Schears(Mayo Clinic in Arizona), Louis A. Schenck(Mayo Clinic), Pablo Moreno Franco(Jacksonville College), Sonal Pannu(Oklahoma City University), Vivek Iyer(Johns Hopkins University), Troy G. Seelhammer(Mayo Clinic in Arizona), Joseph A. Hyder(Brigham and Women's Hospital)
Unknown
January 1, 2016
Cited by 0
Related Papers
Association of Coronary Artery and Aortic Calcium With Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study
|American Journal of Epidemiology|2008|166
Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
|Mayo Clinic Proceedings|2018|125
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
|Mayo Clinic Proceedings|2020|122
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
|JCI Insight|2020|108
Air pollution and respiratory infections: the past, present, and future
|Toxicological Sciences|2023|85